{"meshTagsMajor":["Loss of Heterozygosity","Microsatellite Instability","Mutation"],"meshTags":["Antineoplastic Combined Chemotherapy Protocols","Biomarkers, Tumor","Chromosomes, Human, Pair 18","Colonic Neoplasms","Female","Humans","Loss of Heterozygosity","Male","Microsatellite Instability","Mutation","Proto-Oncogene Proteins","Proto-Oncogene Proteins B-raf","Proto-Oncogene Proteins p21(ras)","Smad4 Protein","ras Proteins"],"meshMinor":["Antineoplastic Combined Chemotherapy Protocols","Biomarkers, Tumor","Chromosomes, Human, Pair 18","Colonic Neoplasms","Female","Humans","Male","Proto-Oncogene Proteins","Proto-Oncogene Proteins B-raf","Proto-Oncogene Proteins p21(ras)","Smad4 Protein","ras Proteins"],"publicationTypes":["Editorial","Comment"],"title":"Combining molecular markers with the TNM staging system to improve prognostication in stage II and III colon cancer: are we ready yet?","pubmedId":"23104213"}